Overview of the EMERALD Trial of Elacestrant in ER+, HER2- Advanced Breast Cancer

The Oncology Brothers are joined by Virginia Kaklamani, MD, DSc, who provides an overview of the EMERALD trial design and use of elacestrant in ER+, HER2- advanced breast cancer.

Now Viewing

EP: 1.Overview of the EMERALD Trial of Elacestrant in ER+, HER2- Advanced Breast Cancer

EP: 2.EMERALD Trial of Elacestrant in ER+, HER2- Advanced Breast Cancer: Efficacy and Safety Data

EP: 3.ER+, HER2- Advanced Breast Cancer: Clinical Implications of the EMERALD Trial

Related Videos